Vector-mediated expression of erythropoietin improves functional outcome after cervical spinal cord contusion injury

Gene Therapy

Volumn 19, Issue 9, 2012, Pages 907-914

  Wang, S ^a   Wu, Z ^a   Chiang, P P ^a   Fink, D J ^a   Mata, M ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

erythropoietin; HSV; spinal cord injury

Indexed keywords

ERYTHROPOIETIN; HERPES SIMPLEX VIRUS VECTOR ERYTHROPOIETIN; HERPESVIRUS VECTOR; NEUROFILAMENT PROTEIN; POSTSYNAPTIC DENSITY PROTEIN 95; SYNAPTOPHYSIN; TAU PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CERVICAL SPINAL CORD INJURY; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FORELIMB; GAIT; GENE EXPRESSION; GENE TRANSFER; GRAY MATTER; MOTOR PERFORMANCE; NONHUMAN; OPEN FIELD TEST; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; REPORTER GENE; STATISTICAL SIGNIFICANCE; SYNAPTOGENESIS; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; CONTUSIONS; ERYTHROPOIETIN; FEMALE; FORELIMB; GENETIC VECTORS; HINDLIMB; MICROTUBULE-ASSOCIATED PROTEINS; NEUROFILAMENT PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; RECOVERY OF FUNCTION; SIMPLEXVIRUS; SPINAL CORD; SPINAL CORD INJURIES; TRANSFECTION;

ANIMALIA; SIMPLEXVIRUS;

EID: 84866100032     PISSN: 09697128     EISSN: 14765462     Source Type: Journal    
DOI: 10.1038/gt.2011.166     Document Type: Article

References (29)

1. Jackson AB, Dijkers M, Devivo MJ, Poczatek RB. A demographic profile of new traumatic spinal cord injuries: change and stability over 30 years. Arch Phys Med Rehabil 2004; 85: 1740-1748.
2. Anderson KD. Targeting recovery: priorities of the spinal cord-injured population. J Neurotrauma 2004; 21: 1371-1383.
3. Grasso G. An overview of new pharmacological treatments for cerebrovascular dysfunction after experimental subarachnoid hemorrhage. Brain Res Brain Res Rev 2004; 44: 49-63.
4. Grasso G, Sfacteria A, Cerami A, Brines M. Erythropoietin as a tissue-protective cytokine in brain injury: what do we know and where do we go? Neuroscientist 2004; 10: 93-98.
5. Brines M, Grasso G, Fiordaliso F, Sfacteria A, Ghezzi P, Fratelli M et al. Erythropoietin mediates tissue protection through an erythropoietin and common beta-subunit heteroreceptor. Proc Natl Acad Sci USA 2004; 101: 14907-14912.
6. Puskovic V, Wechuck J, Krisky D, Collins J, Glorioso JC, Fink DJ et al. HSV-mediated delivery of erythropoietin restores dopaminergic function in MPTP-treated mice. Mol Ther 2006; 14: 710-715.
7. Chattopadhyay M, Walter C, Mata M, Fink DJ. Neuroprotective effect of herpes simplex virus-mediated gene transfer of erythropoietin in hyperglycemic dorsal root ganglion neurons. Brain 2009; 132: 879-888.
8. Zai LJ, Yoo S, Wrathall Jr. Increased growth factor expression and cell proliferation after contusive spinal cord injury. Brain Res 2005; 1052: 147-155.
9. Kwon BK, Okon E, Hillyer J, Mann C, Baptiste D, Weaver LC et al. A systematic review of non-invasive pharmacologic neuroprotective treatments for acute spinal cord injury. J Neurotrauma 2011; 28: 1545-1588.
10. Lee MK, Cleveland DW. Neuronal intermediate filaments. Annu Rev Neurosci 1996; 19: 187-217.
11. Bernaudin M, Marti HH, Roussel S, Divoux D, Nouvelot A, MacKenzie ET et al. A potential role for erythropoietin in focal permanent cerebral ischemia in mice. J Cereb Blood Flow Metab 1999; 19: 643-651.
12. Celik M, Gokmen N, Erbayraktar S, Akhisaroglu M, Konakc S, Ulukus C et al. Erythropoietin prevents motor neuron apoptosis and neurologic disability in experimental spinal cord ischemic injury. Proc Natl Acad Sci USA 2002; 99: 2258-2263.
13. Brines M, Cerami A. Emerging biological roles for erythropoietin in the nervous system. Nat Rev Neurosci 2005; 6: 484-494.
14. Hoffman PN, Griffin JW, Price DL. Control of axonal caliber by neurofilament transport. J Cell Biol 1984; 99: 705-714.
15. Elder GA, Friedrich Jr VL, Kang C, Bosco P, Gourov A, Tu PH et al. Requirement of heavy neurofilament subunit in the development of axons with large calibers. J Cell Biol 1998; 143: 195-205.
16. Mata M, Kupina N, Fink DJ. Phosphorylation-dependent neurofilament epitopes are reduced at the node of Ranvier. J Neurocytol 1992; 21: 199-210.
17. Ransome MI, Turnley AM. Erythropoietin promotes axonal growth in a model of neuronal polarization. Mol Cell Neurosci 2008; 38: 537-547.
18. Kang CE, Poon PC, Tator CH, Shoichet MS. A new paradigm for local and sustained release of therapeutic molecules to the injured spinal cord for neuroprotection and tissue repair. Tissue Eng Part A 2009; 15: 595-604.
19. Siren AL, Fasshauer T, Bartels C, Ehrenreich H. Therapeutic potential of erythropoietin and its structural or functional variants in the nervous system. Neurotherapeutics 2009; 6: 108-127.
20. Ning B, Zhang A, Song H, Gong W, Ding Y, Guo S et al. Recombinant human erythropoietin prevents motor neuron apoptosis in a rat model of cervical sub-acute spinal cord compression. Neurosci Lett 2011; 490: 57-62.
21. Nagai A, Nakagawa E, Choi HB, Hatori K, Kobayashi S, Kim SU. Erythropoietin and erythropoietin receptors in human CNS neurons, astrocytes, microglia, and oligodendrocytes grown in culture. J Neuropathol Exp Neurol 2001; 60: 386-392.
22. Grasso G, Sfacteria A, Passalacqua M, Morabito A, Buemi M, Macri B et al. Erythropoietin and erythropoietin receptor expression after experimental spinal cord injury encourages therapy by exogenous erythropoietin. Neurosurgery 2005; 56: 821-827.
23. Wu Z, Mata M, Fink DJ. Prevention of diabetic neuropathy by regulatable expression of HSV-mediated erythropoietin. Mol Ther 2011; 19: 310-317.
24. Wolfe D, Mata M, Fink DJ. A human trial of HSV-mediated gene transfer for the treatment of chronic pain. Gene Therapy 2009; 16: 455-460.
25. Martinez M, Brezun JM, Bonnier L, Xerri C. A new rating scale for open-field evaluation of behavioral recovery after cervical spinal cord injury in rats. J Neurotrauma 2009; 26: 1043-1053.
26. Schallert T, Fleming SM, Leasure JL, Tillerson JL, Bland ST. CNS plasticity and assessment of forelimb sensorimotor outcome in unilateral rat models of stroke, cortical ablation, parkinsonism and spinal cord injury. Neuropharmacology 2000; 39: 777-787.
27. Bresnahan JC, Beattie MS, Todd III FD, Noyes DH. A behavioral and anatomical analysis of spinal cord injury produced by a feedback-controlled impaction device. Exp Neurol 1987; 95: 548-570.
28. Kunkel-Bagden E, Dai HN, Bregman BS. Recovery of function after spinal cord hemisection in newborn and adult rats: differential effects on reflex and locomotor function. Exp Neurol 1992; 116: 40-51.
29. Basso DM, Beattie MS, Bresnahan JC. A sensitive and reliable locomotor rating scale for open field testing in rats. J Neurotrauma 1995; 12: 1-21.